title: Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
authors.forename: Michael
authors.initials: M
authors.lastname: Lassmann
authors.forename: Markus
authors.initials: M
authors.lastname: Luster
authors.forename: Heribert
authors.initials: H
authors.lastname: Hänscheid
authors.forename: Christoph
authors.initials: C
authors.lastname: Reiners
mesh_terms: D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000473:pathology / Q000528:radiation effects*; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000528:radiation effects; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000032:analysis / Q000627:therapeutic use*; D008297:Male; D015162:Micronucleus Tests; D008875:Middle Aged; D011832:Radiation Injuries / Q000209:etiology* / Q000235:genetics*; D011874:Radiometry / Q000379:methods; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D013961:Thyroid Gland / Q000473:pathology / Q000528:radiation effects*; D013964:Thyroid Neoplasms / Q000097:blood / Q000473:pathology / Q000532:radiotherapy*
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals